KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Hims & Hers Health (HIMS) Return on Sales (2020 - 2025)

Hims & Hers Health's Return on Sales history spans 6 years, with the latest figure at 0.03% for Q4 2025.

  • For Q4 2025, Return on Sales fell 2.0% year-over-year to 0.03%; the TTM value through Dec 2025 reached 0.05%, down 3.0%, while the annual FY2025 figure was 0.05%, 3.0% down from the prior year.
  • Return on Sales for Q4 2025 was 0.03% at Hims & Hers Health, up from 0.03% in the prior quarter.
  • Across five years, Return on Sales topped out at 0.19% in Q3 2024 and bottomed at 0.98% in Q1 2021.
  • The 5-year median for Return on Sales is 0.03% (2023), against an average of 0.09%.
  • The largest annual shift saw Return on Sales plummeted -78bps in 2021 before it surged 82bps in 2022.
  • A 5-year view of Return on Sales shows it stood at 0.37% in 2021, then surged by 82bps to 0.07% in 2022, then skyrocketed by 108bps to 0.01% in 2023, then soared by 971bps to 0.05% in 2024, then tumbled by -38bps to 0.03% in 2025.
  • Per Business Quant, the three most recent readings for HIMS's Return on Sales are 0.03% (Q4 2025), 0.03% (Q3 2025), and 0.08% (Q2 2025).